Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 113 | $113,174,721 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
01 Sep 2023 16:36 | NBIX | NEUROCRINE BIOSCIENCES INC | BOYER DAVID W. | Chief Corp. Affairs Officer | 30 Aug 2023 | Sale | 1,438 | 108.2218 | 155,623 | D |
01 Sep 2023 16:36 | NBIX | NEUROCRINE BIOSCIENCES INC | BOYER DAVID W. | Chief Corp. Affairs Officer | 30 Aug 2023 | Sale | 1,295 | 106.9 | 138,436 | D |
30 Aug 2023 16:38 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 28 Aug 2023 | Sale | 1,431 | 107.52 | 153,861 | D |
23 Aug 2023 20:20 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | 21 Aug 2023 | Sale | 3,198 | 107.3758 | 343,388 | D |
23 Aug 2023 20:10 | NBIX | NEUROCRINE BIOSCIENCES INC | ONYIA JUDE | Chief Scientific Officer | 21 Aug 2023 | Sale | 3,198 | 107.3696 | 343,368 | D |
23 Aug 2023 20:09 | NBIX | NEUROCRINE BIOSCIENCES INC | LIPPOLDT DARIN | Chief Legal Officer | 21 Aug 2023 | Sale | 2,132 | 107.388 | 228,951 | D |
23 Aug 2023 20:08 | NBIX | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | 21 Aug 2023 | Sale | 9,328 | 107.3988 | 1,001,816 | D |
23 Aug 2023 20:05 | NBIX | NEUROCRINE BIOSCIENCES INC | GANO KYLE | Chief Business Development Off | 21 Aug 2023 | Sale | 2,132 | 107.4075 | 228,993 | D |
23 Aug 2023 20:04 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 21 Aug 2023 | Sale | 1,404 | 107.4219 | 150,820 | D |
23 Aug 2023 20:03 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 21 Aug 2023 | Sale | 2,132 | 107.4065 | 228,991 | D |
23 Aug 2023 20:01 | NBIX | NEUROCRINE BIOSCIENCES INC | BOYER DAVID W. | Chief Corp. Affairs Officer | 21 Aug 2023 | Sale | 1,600 | 107.4138 | 171,862 | D |
23 Aug 2023 19:59 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 21 Aug 2023 | Sale | 1,600 | 107.3975 | 171,836 | D |
23 Aug 2023 19:58 | NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | 21 Aug 2023 | Sale | 2,132 | 107.3914 | 228,958 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)